We are a clinical research team delivering patient-centric clinical investigations across Europe and MENA. We combine strong site access with DCT/hybrid delivery, an integrated digital trial stack (eTMF, eCRF, eCOA, RTSM), and risk-based monitoring to start fast, run clean, and stay audit-ready.
Products, services, technology
Our team covers data management + study operations and provides medical writing + submission-ready document support by Fast-track Package to shorten trial start-up timeline; end-to-end digital stack integrating all EDC systems; and Risk-Based Monitoring to maintain oversight while reducing rework.
Cooperation possibilities
Developer teams can accelerate evidence generation with us through a pan‑European site network and proven DCT/hybrid manuals. We also deliver (i) EU CTR workshops to cut submission friction, and (ii) DCT design sessions to pressure‑test protocol feasibility, logistics, and data integrity pre‑launch.
- +41 78 241 06 72
- Send an email
- Zoltan SAGI
Some insights
We accelerate life-changing clinical research by delivering high-quality, compliant and compassionate CRO services across Europe. We connect sponsors with patients faster, broaden access to innovative therapies and uphold the highest ethical standards to improve global health.
I’m proud of our passionate team of experts – from PIs to research nurses – delivering compliant, efficient, compassionate clinical trials across Europe. Our focus on quality, patient well-being, and faster access to innovative therapies drives better health outcomes.
Current strengths: experienced PIs, CRAs and PMs; GCP/EMA compliance; European site network; risk-based & decentralised trial expertise; patient-centric care. Future: advanced biostatistics & data management, AI-driven monitoring, digital eClinical tools.
"He is always on the phone with medicine bosses, planning tests for new drugs and medical devices in places like Hungary, Czech Republic and Poland. Figures out the rules, money, and calendars, then hurries home so we can eat dinner together."
By collaborating with Swiss KoLs and Sponsors, we can co-develop innovative therapies, leverage eClinical platforms and CEE PI networks, and integrate advanced biostatistics and AI tools for faster, data-rich trials that benefit patients and stakeholders alike.
I’d welcome introductions to CxOs at sponsor organizations eager to launch clinical trials in Central and Eastern Europe.
